60 results
F-3
CANF
Can-Fite Biopharma Ltd
1 Sep 23
Shelf registration (foreign)
4:15pm
OF DISTRIBUTION
The securities being offered by this prospectus may be sold:
through agents;
to or through one or more underwriters on a firm commitment … bidding or auction process, on a negotiated basis or otherwise; to or through one or more underwriters on a firm commitment or best efforts basis
424B5
CANF
Can-Fite Biopharma Ltd
13 Aug 21
Prospectus supplement for primary offering
4:46pm
investors. The engagement agreement does not give rise to any commitment by the placement agent to purchase any of our securities, and the placement agent … offered by this prospectus may be sold:
through agents;
to or through one or more underwriters on a firm commitment or agency basis;
through put or call
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
16 Mar 21
Can-Fite Signs $42.7 Million Out-Licensing Deal with Ewopharma
7:08am
long-standing commitment to its entire region.”
About Piclidenoson
Piclidenoson is a novel, first-in-class, A3 adenosine receptor agonist (A3AR
F-3
CANF
Can-Fite Biopharma Ltd
25 Sep 20
Shelf registration (foreign)
4:37pm
;
to or through one or more underwriters on a firm commitment or agency basis;
through put or call option transactions relating to the securities … or more underwriters on a firm commitment or best efforts basis;
exchange distributions and/or secondary distributions;
ordinary brokerage transactions
424B5
6tp3mqwbdt5ji71cl2
8 Jul 20
Prospectus supplement for primary offering
10:42am
424B5
ndrjakqlzs sx9yesu
12 Jun 20
Prospectus supplement for primary offering
8:30am
424B3
tkg2t4g
1 Jun 20
Prospectus supplement
7:23am
6-K
EX-99.2
prhu2wm6ovt2qi3gw7e
1 Jun 20
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
1vrqrjzjvl4yblzk
1 Jun 20
Report of Foreign Private Issuer
7:06am
6-K
EX-99.1
csjqh43889j qpz
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
b4coxvsc3ra888 h72
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
djqkpwd
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
jft wi9igyl
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
ueoqphm1elkq7688zxt
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
6-K
EX-99.1
gv4prn
6 Nov 19
2019 Annual General Meeting of Shareholders
4:42pm
F-1/A
EX-10.1
mw9c91 bd2bsoi0
17 Oct 19
Registration statement (foreign) (amended)
5:29pm
F-1/A
EX-10.2
js5zooviz9uc ygy
17 Oct 19
Registration statement (foreign) (amended)
5:29pm
6-K
EX-99.1
2zplh
1 Aug 19
Can-Fite Signs Agreement with Kyongbo Pharm for the Distribution in South Korea of Piclidenoson in the Treatment of Psoriasis
9:01am